EMV emvision medical devices ltd

1.71%

$1.72

Interview with Scott Kirkland CEO EMV and some notes., page-3

First 3 Last

Share
Profile

Follow
vintage

13,877 Posts.

2983

29/07/23

06:40

Post #: 69050428
Share

Originally posted by Eire2011 ↑

https://podcasts.apple.com/au/podcast/equity-mates-investing-podcast/id1212097275?i=1000622561174

EMV - a general summary of some important points in the Equity Mates podcast interview with Scott Kirkland (well worth a listen)

Two main ways to market - capital sales and service or subscription model.

Capital sales - $225k AUD per device - EMV $25 per scan (US) approx $37 AUD with very healthy margins on the consumables.
10% in servicing expected of the capital cost per annum. About $22k per year.
Or subscription model $8k US per month subscription model which includes everything (device, training, accessories, consumables etc) but has a cap on number of consumables - if they go over they pay a seperate fee on top of that.

Gen 1 - ICU - Stroke wards both with a view to monitoring paradigm to keep an eye on patients. Emergency departments for regional hospitals where CT may not be available etc. 2.5 billion market for Gen 1 just in:
US 10,000 opportunities
Germany, France and Uk - $6,000 opportunities
Australia - 500 opportunities

“Equals $2.5 billion market - add in South Korea, Japan, China and Latin America and that number gets very very big.”

We believe the design of our study will produce data that will support regulatory submissions in the major markets.

Initial market to get a foothold will be in primary and comprehensive stroke centres - 1600 in the US and similar numbers in Germany, France and the UK so this would be the lower hanging fruit for EMV and represents about $350 million revenue opportunity (note this is only early targets and Gen 1 device only).

We need a good body of evidence and an effective podium strategy. 5% to 10% of end users will be early adopters while others will wait for more publications and public outcomes etc.

Ultimate goal is to get into guidelines - not an over night journey but there is a process and a pathway to get there. Working on Reimbursement strategies in the US and “New technology add on payment” - some information here - https://www.prmaconsulting.com/blog...es additional,years for a specific indication.

As we progress through the current study we would like to be able to make insights as we did in the previous study. We are also working on our go to market partnerships currently. We expect to work with distributors for our major markets especially the US. Will be at the RSNA (one of the largest medical imaging conferences.) https://www.rsna.org/?gad=1&gclid=EAIaIQobChMI173q2cawgAMVV81MAh0ysAngEAAYASAAEgLPcPD_BwE in Chicago later this year (Nov 26th to 30th) to work on this.

EMV - 10 to 20 years down the line?

Our motto (learned from Ron) - Do one thing and do it well. We don’t need 7 products to be a multi billion dollar business. With our two main devices focusing on stroke we can be a very successful business.

But there are opportunities to use the same hardware with essentially a software upgrade to tackle other indications like traumatic brain injury, falls and brain swelling etc.

There is a whole lot of opportunity to expand out our existing product line and then later it is a platform technology and we own the rights for looking at lung, liver skin etc.

But we want a healthy business on our existing product line first and then tackle other markets down stream.

Expand

That reads so well!

We appear to be invested in the perfect quinella here.

An investment with huge medium and long term potential to build wealth.

But also a deliciously ethical investment - one with the potential to save, improve and extend countless lives. And also one with a low carbon footprint.

EMV Price at posting: $1.24 Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

ILU

Rare earths stocks surge as Pentagon buys big stake in US REE miner

AAU

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

VMM

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

AII

Inside the depths of Panasqueira: A legacy carved in rock

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

LIS

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

CWX

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Trump just dropped a 200% tariff bomb. Here's how to cash in

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.72		Change -0.030(1.71%)		Mkt cap ! $147.0M

Open	High	Low	Value	Volume
$1.73	$1.77	$1.72	$9.824K	5.636K

Buyers (Bids)

No.	Vol.	Price($)
2	1455	$1.72

Sellers (Offers)

Price($)	Vol.	No.
$1.77	2000	1

View Market Depth

No.	Vol.	Price($)
2	1455	1.720
1	500	1.715
2	2169	1.710
2	3055	1.705
9	37376	1.700

Price($)	Vol.	No.
1.770	2000	1
1.795	3600	1
1.800	6575	2
1.825	2462	1
1.840	3000	1

Last trade - 16.10pm 11/07/2025 (20 minute delay)

EMV (ASX) Chart

Interview with Scott Kirkland CEO EMV and some notes., page-3

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Inside the depths of Panasqueira: A legacy carved in rock

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Trump just dropped a 200% tariff bomb. Here's how to cash in

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Interview with Scott Kirkland CEO EMV and some notes., page-3

Top Stories

Rare earths stocks surge as Pentagon buys big stake in US REE miner

Antilles brings Chinese ally on board to keep Neuva Sabana work chugging on

HotCopper Highlights: RIP to Botanix (for now); Droneshield new ATH; Trigg mystery halt

'Big tick': Viridis positions for global leadership with Colossus pre-feasibility study

Inside the depths of Panasqueira: A legacy carved in rock

Week 28 Wrap: Tariff chaos back for some reason; CBA holds strong

'Opens doors': Li-S Energy the first Oz company to produce lithium metal foils

Carawine faces Fraser Range JV collapse as IGO moves to scrap partnership

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Trump just dropped a 200% tariff bomb. Here's how to cash in

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News